Axonal Degeneration Is Blocked by Nicotinamide Mononucleotide Adenylyltransferase (Nmnat) Protein Transduction into Transected Axons
Open Access
- 1 December 2010
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 285 (53) , 41211-41215
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Transgenic Mice Expressing the Nmnat1 Protein Manifest Robust Delay in Axonal DegenerationIn VivoJournal of Neuroscience, 2009
- Nicotinamide Mononucleotide Adenylyltransferase Expression in Mitochondrial Matrix Delays Wallerian DegenerationJournal of Neuroscience, 2009
- Nicotinamide Mononucleotide Adenylyl Transferase-Mediated Axonal Protection Requires Enzymatic Activity But Not Increased Levels of Neuronal Nicotinamide Adenine DinucleotideJournal of Neuroscience, 2009
- A dual leucine kinase–dependent axon self-destruction program promotes Wallerian degenerationNature Neuroscience, 2009
- NAD synthase NMNAT acts as a chaperone to protect against neurodegenerationNature, 2008
- Axon degeneration mechanisms: commonality amid diversityNature Reviews Neuroscience, 2005
- A local mechanism mediates NAD-dependent protection of axon degenerationJournal of Cell Biology, 2005
- Passive and Active Inclusion of Host Proteins in Human Immunodeficiency Virus Type 1 Gag Particles during Budding at the Plasma MembraneJournal of Virology, 2004
- Critical Factors Influencing Stable Transduction of Human CD34+ Cells with HIV-1-Derived Lentiviral VectorsMolecular Therapy, 2000
- Multiply attenuated lentiviral vector achieves efficient gene delivery in vivoNature Biotechnology, 1997